Founded in 2001, Deep Breeze Ltd. is a privately owned medical device company backed by financial partners: SCP, Vitalife VC, Nisko Arden, Aviv Ventures & Union Investment Enterprise. In joint partnership with GE Healthcare, Deep Breeze Ltd. introduced its Critical Care device VRIxv™ in Europe during October 2007.

Concept 

The VRIxp™ system is based on Vibration Response generated by the air passing through the lungs. The system records these vibrations and then uses an algorithm to convert the data into images. Changes in tissue composition or alteration in airflow impact how sounds within the lungs vibrate, and subsequently how the images by the VRIxp™ device appear on the system’s computer screen. The result offers physicians a dynamic lung image obtained passively at the bedside, & without radiation. Thousands of patients have been recorded by the VRIxp™ device worldwide during clinical investigations without any single adverse event. 

The VRI™ technology received the FDA 510K clearance via the pre-market  notification process for Marketing in the USA in August 2007, the approval of registration by the State Food and Drug Administration (SFDA) of the People's Republic of China in January 2008, the Korean Food and Drug Administration Approval in January 2007, the  Medical Device and Accessories approval by  the Israeli Minister of Health in January 2006, and was granted the CE mark in September 2005. 
Deep Breeze Ltd. is ISO 13485 Medical Devices Quality Management Systems certified.